Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 901–1,000 of 1,000
Cellular and animal models of type 2 diabetes GWAS gene polymorphisms: what can we learn?
Rutter, G. A. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2013.02.002 · Cited by 2
Inherited pediatric metabolic epilepsies
Pearl, P. L., & Yu, Y. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.758580 · Cited by 2
“The disorder is an epileptic channelopathy associated with gain-of-function mutations in a variety of potassium channel and sulfonylurea receptor genes Expert Opinion on Orphan Drugs (2013) 1(2) 119 (some of the more common being KCNJ11, encoding a subunit of the potassium channel Kir6 and ABCC8 encoding the sulfonylu…”
BackgroundInfluentialCost-Effectiveness of Genetic Testing for Monogenic Diabetes
Naylor, R. N., Greeley, S. A. W., & Huang, E. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00027-0 · Cited by 2
ATP-Sensitive Potassium Channels in Health and Disease
Proks, P., & Clark, R. H. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_6 · Cited by 3
Self-citationMetabolic and endocrine disorders
Martin, R. J., Fanaroff, A. A., & Walsh, M. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06545-0.00058-3 · Cited by 3
Biosynthesis, Processing, and Secretion of the Islet Hormones
Steiner, D. F., Rhodes, C. J., Philipson, L. H., Bell, G. I., & Chan, S. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00031-7 · Cited by 3
Uncommon Presentations of Diabetes: Zebras in the Herd
Shidler, K. L., Letourneau, L. R., & Novak, L. M. (2019) · Clinical Diabetes · doi:10.2337/cd19-0019 · Cited by 4
“This mutation was previously reported to be associated with neonatal diabetes (88).”
BackgroundPhenotype of a transient neonatal diabetes point mutation (SUR1-R1183W) in mice
Sachse, G., Haythorne, E., Proks, P., Stewart, M. E., Cater, H. L., Ellard, S., Davies, B., & Ashcroft, F. M. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15529.2 · Cited by 2
“Activating mutations in either KCNJ11 or ABCC8 are a common cause of neonatal diabetes (NDM) (De Franco et al., 2015; Edghill et al., 2010; Flanagan et al., 2009; Gloyn et al., 2004).”
Self-citation丸山, 幸., 基正, 鈴., 俊幸, 熊., & 清邦, 三. (2009) · PubMed · doi:10.11251/ojjscn.41.299 · Cited by 2
Bizzarri, C., Schiaffini, R., & Patera, I. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-07008-2_1 · Cited by 2
Molecular Genetic Disorders of Fetal Growth
Chernausek, S. D. (2008) · Pediatric and adolescent medicine · doi:10.1159/000165981 · Cited by 2
Messenger RNA processing and its role in diabetes
Harries, L. W. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03373.x · Cited by 3
Transient Neonatal Diabetes Mellitus: A Challenge and Opportunity for Specialized Nursing Care
Zammit, M. A., Agius, S. M., & Calleja‐Agius, J. (2017) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.36.4.196 · Cited by 2
The personalized approach to neonatal diabetes therapy depending on the genetic defect
Tikhonovich, Y. V., Zubkova, N. V., & Tiulpakov, A. N. (2017) · World Journal of Personalized Medicine · doi:10.14341/wjpm9304 · Cited by 2
Precision medicine for a man presented with diabetes at 2-month old
Ang, S. F., Tan, C. S. H., Fong, J. C. W., & Lim, S. C. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0371-z · Cited by 2
Adelman, J. P., Clapham, D. E., Hibino, H., Inanobe, A., Jan, L. Y., Karschin, A., Kubo, Y., Kurachi, Y., Lazdunski, M., Miki, T., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f74/2019.4 · Cited by 2
Mohora, R., & Stoicescu, S.-M. (2016) · Europe PMC (PubMed Central) · Cited by 2
Molecular medicine of diabetes mellitus
Kumar, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00015-0 · Cited by 2
Song, L., Barrett, D. G., Cox, K. L., Efanov, A. M., Syed, S. K., Tomandl, D., & Willard, F. S. (2020) · Assay and Drug Development Technologies · doi:10.1089/adt.2020.1011 · Cited by 2
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_7 · Cited by 7
Evidence-Based Medicine in Pediatric Endocrinology
Butler, G. E. (2010) · Yearbook of pediatric endocrinology · doi:10.1159/000320662 · Cited by 2
“HLA studies and the association with ATP-sensitive K channel mutations revealed that patients diagnosed with diabetes before 6 months of age are more likely to be monogenic than type 1 diabetes in origin [6, 7].”
BackgroundRutter, G. A. (2007) · KARGER eBooks · doi:10.1159/000109607 · Cited by 2
Aetiology of Type 1 Diabetes Mellitus ‐ Genetics, Autoimmunity and Trigger Factors
Marcovecchio, M. L., Dunger, D. B., Peakman, M., & Taylor, K. W. (2007) · Wiley eBooks · doi:10.1002/9780470692271.ch3 · Cited by 3
Coffee and Risk of Type 2 Diabetes
Bidel, S., & Tuomilehto, J. (2007) · Työväentutkimus Vuosikirja · Cited by 4
2. 1) Insulin-secretion Inducing Oral Hypoglycemic Agents
Nagashima, K., & Inagaki, N. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.737 · Cited by 2
Misra, S., & Hattersley, A. T. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch18 · Cited by 3
Self-citationActionability of Genetic Variants in Diabetes: Core Aspects and Applied Examples
Yvonnet, S., Reim, P. K., & Thuesen, A. C. B. (2025) · Diabetes Spectrum · doi:10.2337/ds24-0081 · Cited by 1
“In others, it was because of a lack of robust gene-disease association data (23) (e.g., BLK, KLF11, and PAX4 ), or practical constraints, such as challenges in variant interpretation (24) (e.g., ABCC8 and KCNJ11 ) or the expectation of a low diagnostic yield for ultra-rare forms of monogenic diabetes, such as neonatal…”
Davarzani, A., Ravanbod, M., Ghasemi, A., Mohammadi, M., Rohani, M., Nafissi, S., Jamali, P., Najmabadi, H., Fatehi, F., Alavi, S., et al. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04373-8 · Cited by 1
“Also, pathogenic variants in various KCNJ genes, including KCNJ10 , KCNJ11 , and KCNJ6 [107–109] are already known to cause diverse neurological disorders.”
Scala, R., Chen, Y., Mizrak, B., Meyer, G. A., & Nichols, C. G. (2026) · The Journal of General Physiology · doi:10.1085/jgp.202613986 · Cited by 2
Diabetes mellitus neonatal transitoria e inversión pericéntrica del cromosoma 9
Martos‐Moreno, G. Á., Calvo, M. A. M., Díaz, M. A. M., Román, J. P., & Oliver, J. A. (2006) · Anales de Pediatría · doi:10.1157/13092170 · Cited by 1
Thewjitcharoen, Y., Wanothayaroj, E., Himathongkam, T., Flanagan, S. E., Ellard, S., & Hattersley, A. T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.003 · Cited by 1
Self-citationDiabetes mellitus en la infancia: una enfermedad heterogénea
Cabezas, Ó. R., & Oliver, J. A. (2007) · Medicina Clínica · doi:10.1157/13101746 · Cited by 1
Neonatal hyperglycaemia: a challenging diagnosis: Figure 1
Prado, S. N., Amaral, R., Tomé, T., Bettencourt, A., Pinto, F., & Rocha, T. (2010) · BMJ Case Reports · doi:10.1136/bcr.12.2008.1385 · Cited by 1
“In contrast to the transient form, the aetiology of PNDM is more heterogeneous. Causes identified include genetic conditions resulting in abnormalities of pancreatic development or function such as: (1) mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2, being the most common cause of PN…”
DNA Variations, Impaired Insulin Secretion and Type 2 Diabetes
Lyssenko, V., & Groop, L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_12 · Cited by 1
“Slettet: [27]”
Genetically Programmed Defects in β-Cell Function
Pal, A., & Gloyn, A. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_13 · Cited by 1
Self-citationGenetics of Drug Response in Diabetes
Pearson, E. R., & Florez, J. C. (2014) · Frontiers in diabetes · doi:10.1159/000362475 · Cited by 1
Self-citationFuruya, A., Suzuki, S., Oshima, M., Amamiya, S., Nakao, A., Araki, M., Mizutani, K., Hayano, S., Ushijima, K., Imamoto, A., et al. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21985 · Cited by 1
“The main cause of PNDM is abnormality of the KCNJ11 gene which constitutes the ATP-sensitive potassium channel of pancreatic b cells; PNDM develops at 7 weeks after birth on average (3, 4).”
Backgroundde Groot, M., & Klungel, O. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139051194.017 · Cited by 1
Pharmacogenomic Applications in Children
Grant, S. F. A., & Hakonarson, H. H. (2008) · Methods in pharmacology and toxicology · doi:10.1007/978-1-59745-439-1_20 · Cited by 1
Neonatal diabetes in Ukraine: modern diagnostic and therapeutic approaches
Вікторівна, Г. Є. (2015) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.2(50).2015.74986 · Cited by 1
Management of Diabetes Mellitus in Children
Wolfsdorf, J. I., & Botero, D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00049-6 · Cited by 1
Owen, K. R. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_10 · Cited by 1
Precision diabetes is becoming a reality in India
Mohan, V., & Radha, V. (2022) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-022-00115-z · Cited by 1
Neonatal Hypoglycemia and Hyperglycemia
Werny, D. M., Huang, A., Tenney, J., & Pihoker, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00087-8 · Cited by 1
Research progress of brain organoids in the field of diabetes
Su, Y., Liu, A., Chen, H., Chen, Q., Zhao, B., Gao, R., Zhang, K., Peng, T., Zhang, Z., Ouyang, C., et al. (2024) · Molecular Brain · doi:10.1186/s13041-024-01123-4 · Cited by 2
“Due to the altered functionality of these KATP channels, the beta cells within the islets are incapable of secreting insulin, Consequently, this results in elevated blood sugar levels [56].”
BackgroundZhou, T., Zhao, Z., Zhang, H., Song, Y., Yin, Y., Wu, F., Liu, Y., & Xu, D. (2025) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2025.05.002 · Cited by 1
“…in regulation the potassium balance [2], and are closely associated with numerous human diseases, such as Bartter syndrome (type II) [3], epilepsy [4], persistent hyperinsulinemic hypoglycemia of infancy [5], developmental retardation [6], malformation, and snowflake vitreoretinopathy [7].”
Müller, G. A. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_158-1 · Cited by 1
Clinical and genetic features of permanent neonatal diabetes mellitus
Al-Agha, A. E., & Ahmad, I. A. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0398-9 · Cited by 1
“But, in addition to these, the sulfonylurea treatment also has some side effects like abdominal pain and diarrhea which are almost negligible, temporary, and mild [13].”
BackgroundMusa, N., Hafez, M. M., Hassan, M. M., El‐Mougy, F., Sharaf, S. A. E.-A., Polak, M., Cavé, H., & Mofeed, S. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0431-z · Cited by 1
“sensitive potassium (KATP) channel [7].”
BackgroundDiabetes mellitus neonatal y mutación del gen KCNJ11: presentación de un caso familiar
Hernández, M. O., Martínez, M. D. L. S., Casado, I. G., Lapunzina, P. D., & Bouthelier, R. G. (2008) · Anales de Pediatría · doi:10.1157/13123293 · Cited by 1
Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Brown, K. M., & Shuldiner, A. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_10 · Cited by 1
Soler, G. S., Manga, B., Navarro-Falcón, M., & Codina, M. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.10.002 · Cited by 1
¿Por qué debemos preocuparnos de diagnosticar una diabetes monogénica?
Carrasco, A. J. B. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.07.001 · Cited by 1
Monogenic diabetes and the role of the diabetes nurse
Shepherd, M. H. (2014) · European Diabetes Nursing · doi:10.1002/edn.242 · Cited by 1
Dedov, I. I., Тихонович, Ю. В., Петряйкина, Е. Е., Rybkina, I. G., Волков, И. Э., Стотикова, О. В., Черных, Л. Г., & Tiulpakov, A. N. (2011) · Problems of Endocrinology · doi:10.14341/probl20115723-8 · Cited by 2
LANDSCAPE OF MONOGENIC DIABETES IN THE THIRD MILLENIUM
Guja, C., Guja, L., Gagniuc, P. A., & Ionescu-Tîrgovite, C. (2013) · Cited by 5
Qu, H., & Polychronakos, C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_21 · Cited by 1
Genetic Susceptibility to Transient and Permanent Neonatal Diabetes Mellitus
Tezerjani, M. D., Mehrjardi, M. Y. V., Kalantar, S. M., & Dehghani, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Historical Overview of Gene Discovery Methodologies in Type 2 Diabetes
Bonnefond, A., Shuldiner, A. R., & Froguel, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_1 · Cited by 1
Pharmacogenetics of Sulfonylureas
Kovacs, P. L., & Pearson, E. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_23 · Cited by 1
“Early work showed a robust insulin secretory response to intravenous tolbutamide in 3 patients (who had minimal insulin response to glucose) (Gloyn et al. 2004; Hattersley and Ashcroft 2005; Flanagan et al. 2007).”
BackgroundSelf-citationTransient Neonatal Diabetes due to a Mutation in KCNJ11 in a Child with Klinefelter Syndrome
DAHL, A. R., Dhamija, R., Nofal, A. A., Pittock, S. T., Schwenk, W. F., & Kumar, S. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.4807 · Cited by 1
“are noteworthy since heterozygous activating mutations in KCNJ11 are seen in only a small number of patients with TNDM (12) and instead comprise the most common cause of permanent neonatal diabetes (24,25,26).”
BackgroundNeonatal Diabetes Mellitus: A Tale Still to Resolve
Raghav, A. (2017) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2017.04.555643 · Cited by 1
“2 subunit of the potassium ATPase complex, that involve in regulation of potassium ion across the membrane [16].”
BackgroundGenetic Contributions and Personalized Medicine
Hicks, J. K., & Dunnenberger, H. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-71812-5_1 · Cited by 1
Contribution of systemic inflammation to permanence of KATP-induced neonatal diabetes in mice
Emfinger, C. H., Yan, Z., Welscher, A., Hung, P., McAllister, W., Hruz, P. W., Nichols, C. G., & Remedi, M. S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00137.2018 · Cited by 1
“NDM patients with KATP-GOF mutations are now treated with sulfonylurea (SU) drugs, also widely used to treat type 2 diabetic patients, directly inhibiting KATP channels to restore endogenous insulin secretion (25, 33).”
BackgroundInfluentialDiabetes in Children and Adolescents
Yosypiv, I. V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_6 · Cited by 1
Potassium Channel Mutations in Epilepsy
Palmer, E. E. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190669164.013.13 · Cited by 1
Electrophysiology of Islet Cells
Drews, G., Krippeit‐Drews, P., & Düfer, M. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_5-2 · Cited by 2
Knupp, K. G., & Brooks‐Kayal, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00049-7 · Cited by 2
ATP-Sensitive Potassium Channels in Health and Disease
Proks, P., & Ashcroft, F. M. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_20 · Cited by 1
Self-citationPrecision medicine in diabetes - current trends and future directions. Is the future now?
Szczerbiński, Ł., & Florez, J. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00021-6 · Cited by 1
A Practical Approach to the Diagnosis of Type 1 Diabetes: An Indian Perspective
Kumaran, S., Lalvani, N., Jevalikar, G., Sarda, A., & Unnikrishnan, A. G. (2023) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_19_22 · Cited by 1
The Genomics of Diabetic Neuropathy
Veluchamy, A., Smith, B. H., & Bennett, D. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_14 · Cited by 1
Infantile onset diabetes mellitus
Kochar, I. S. (2013) · Indian Pediatrics · doi:10.1007/s13312-013-0205-y · Cited by 1
“Nearly half of all cases of permanent neonatal diabetes are due to activating mutations in KCNJ11 or ABCC8; their diabetes can be remarkably well controlled by oral sulfonylurea instead of injected insulin [1,2].”
BackgroundAlchemy in the Soup: Transforming Metabolic Signals to Excitability
Nichols, C. G. (2007) · Science s STKE · doi:10.1126/stke.4102007pe59 · Cited by 1
Type 2 Diabetes Mellitus ‒ Genetics, Diagnosis and Management. Polycystic Ovarian Syndrome
Porter, J., & Barrett, T. G. (2007) · Wiley eBooks · doi:10.1002/9780470692271.ch12 · Cited by 1
Gloyn, A. L. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02860.x · Cited by 1
Self-citationMonogenic Forms of Diabetes in the Young
Vaxillaire, M., & Froguel, P. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-12 · Cited by 1
Fatty Acid and Glucose Metabolism in Cardiac Disease
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50016-4 · Cited by 1
The molecular and genetic basis of type 2 diabetes mellitus
Wei, N., & Florez, J. C. (2009) · Dialnet (Universidad de la Rioja) · Cited by 3
Systematic Review of Monogenic Diabetes PrognosticsPreprint
Naylor, R. N., Amouyal, C., Philipson, L. H., Vatier, C., Dickens, L. T., PMDI, A., & Greeley, S. A. W. (2023) · medRxiv · doi:10.1101/2023.05.19.23290220 · Cited by 1
Nakhe, A. Y., Dadi, P. K., Kim, J., Shrestha, S., Cartailler, J., Sampson, L. L., Magnuson, M. A., & Jacobson, D. A. (2023) · eLife · doi:10.7554/elife.89967.1 · Cited by 1
Gene x lifestyle interactions in type 2 diabetes mellitus and related traits
Brito, E. C. (2010) · DiVA at Umeå University (Umeå University)
Un nouveau mécanisme et peut-être un traitement inattendu pour certains diabètes du nouveau-né
Raffin‐Sanson, M. (2004) · EMC - Endocrinologie · doi:10.1016/j.emcend.2004.08.001
Transienter neonataler Diabetes und Hypomethylierungssyndrome
Bens, S., Siebert, R., & Caliebe, A. (2010) · Medizinische Genetik · doi:10.1007/s11825-010-0246-8
Pharmacogenomics and Organ Transplantation
Burckart, G. J., & Watanabe, R. M. (2010) · Wiley eBooks · doi:10.1002/9781444355628.ch10
Diabetes mellitus neonatal en Costa Rica
Salazar, F. R., Padilla, E. R., Bogarin, R., Aita, F. C., & Jaramillo-Lines, O. (2020) · Acta Médica Costarricense · doi:10.51481/amc.v56i3.848
Monogenic diabetes and pancreatic exocrine dysfunction in mouse and man
Vesterhus, M. N. (2009) · NVA (Nasjonalt vitenarkiv)
Hamilton-Shield, J. P., Malecki, M. T., Bridges, N., & Allgrove, J. (2007) · Wiley eBooks · doi:10.1002/9780470692271.ch13
Mutações Genéticas Relacionadas com o Diabetes Melito Neonatal
Moreira, B. C., Rosado, F. R., Fiorini, A., & Mendes, F. C. V. (2009) · Saúde e Pesquisa
Translating Advances in Our Understanding of the Genetics of Diabetes into the Clinic
Gardner, D. S.-L., Owen, K. R., & Gloyn, A. L. (2014) · Frontiers in diabetes · doi:10.1159/000362476
Self-citationSimmons, C. R. (2011) · UKnowledge (University of Kentucky)
Monogenic Disorders of the β‐Cell
Pearson, E. R., & Hattersley, A. T. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0406
Self-citationMechanisms of defective insulin secretion in type 2 diabetes
Mahdi, T. (2013) · Lund University Publications (Lund University)
Maturity-Onset Diabetes of the Young: Molecular Genetics, Clinical Manifestations, and Therapy
Stoffel, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_14
Exploring the Grey Zone between Type 1 and Type 2 Diabetes
Bakhtadze, E. (2009) · Lund University Publications (Lund University) · Cited by 1
Signaling in Diabetes and Metabolic Syndrome
Marín-García, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9461-5_16
Neonatal Diabetes – From Gene Discovery yo Clinical Practice Changes
Guja, C., Guja, L., & Ionescu-Tirgoviste, C. (2013) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2013-0034
“The hypothesis was first confirmed in 2004 by Anna Gloyn and colleagues who reported PNDM caused by activating dominantlyinherited mutations in the KCJN11 gene [26].”
BackgroundPharmacogenomics: Single Genes, Whole Genomes and Global Networks
Kennedy, M. A. (2007) · Personalized Medicine · doi:10.2217/17410541.4.1.87
What are the practical implications of developments in genetics?
Pearson, E. R. (2010) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2010.s02
Self-citationAspectos clínicos y diagnósticos de la diabetes infantil
Bouhours‐Nouet, N., & Coutant, R. (2011) · EMC - Pediatría · doi:10.1016/s1245-1789(11)71180-5 · Cited by 2
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.